HFSA's 2026 Annual Scientific Meeting to Feature Late-Breaking Trials That Could Reshape Heart Failure Treatment

ConferencePositive

AI Analysis

Summary

The Heart Failure Society of America announced its 2026 Annual Scientific Meeting (October 9-12 in Phoenix) will feature late-breaking clinical research trials covering pharmacotherapy, imaging, diagnostics, and device therapy for cardiomyopathy patients.

Importance:3/10

Sentiment:

0.30

heart failurecardiomyopathyclinical researchpharmacotherapydevice therapyimaging diagnosticslate-breaking trials

Related Companies

$AAGH

Read the original article

Published by PR Newswire Pharma on September 18, 2026 1:17 PM

Read Original